Anxiolytics may promote locomotor function recovery in spinal cord injury patients

Pierre A GuertinNeuroscience Unit, Laval University Medical Center (CHUL), Quebec City, CanadaAbstract: Recent findings in animal models of paraplegia suggest that specific nonbenzodiazepine anxiolytics may temporarily restore locomotor functions after spinal cord injury (SCI). Experiments using in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Pierre A Guertin
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/f41864b083a24af1922bef312e67addf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f41864b083a24af1922bef312e67addf
record_format dspace
spelling oai:doaj.org-article:f41864b083a24af1922bef312e67addf2021-12-02T04:21:37ZAnxiolytics may promote locomotor function recovery in spinal cord injury patients1176-63281178-2021https://doaj.org/article/f41864b083a24af1922bef312e67addf2008-09-01T00:00:00Zhttp://www.dovepress.com/anxiolytics-may-promote-locomotor-function-recovery-in-spinal-cord-inj-a2201https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Pierre A GuertinNeuroscience Unit, Laval University Medical Center (CHUL), Quebec City, CanadaAbstract: Recent findings in animal models of paraplegia suggest that specific nonbenzodiazepine anxiolytics may temporarily restore locomotor functions after spinal cord injury (SCI). Experiments using in vitro models have revealed, indeed, that selective serotonin receptor (5-HTR) ligands such as 5-HTR1A agonists, known as relatively safe anxiolytics, can acutely elicit episodes of rhythmic neuronal activity refered to as fictive locomotion in isolated spinal cord preparations. Along the same line, in vivo studies have recently shown that this subclass of anxiolytics can induce, shortly after systemic administration (eg, orally or subcutaneously), some locomotor-like hindlimb movements during 45–60 minutes in completely spinal cord-transected (Tx) rodents. Using ‘knock-out’ mice (eg, 5-HTR7-/-) and selective antagonists, it has been clearly established that both 5-HTR1A and 5-HTR7 were critically involved in mediating the pro-locomotor effects induced by 8-OH-DPAT (typically referred to as a 5-HTR1A agonist) in Tx animals. Taken together, these in vitro and in vivo data strongly support the idea that 5-HTR1A agonists may eventually become constitutive elements of a novel first-in-class combinatorial treatment aimed at periodically inducing short episodes of treadmill stepping in SCI patients.Keywords: 5-HT agonists, anxiolytics, locomotion, SCI Pierre A GuertinDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 4, Pp 759-763 (2008)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Pierre A Guertin
Anxiolytics may promote locomotor function recovery in spinal cord injury patients
description Pierre A GuertinNeuroscience Unit, Laval University Medical Center (CHUL), Quebec City, CanadaAbstract: Recent findings in animal models of paraplegia suggest that specific nonbenzodiazepine anxiolytics may temporarily restore locomotor functions after spinal cord injury (SCI). Experiments using in vitro models have revealed, indeed, that selective serotonin receptor (5-HTR) ligands such as 5-HTR1A agonists, known as relatively safe anxiolytics, can acutely elicit episodes of rhythmic neuronal activity refered to as fictive locomotion in isolated spinal cord preparations. Along the same line, in vivo studies have recently shown that this subclass of anxiolytics can induce, shortly after systemic administration (eg, orally or subcutaneously), some locomotor-like hindlimb movements during 45–60 minutes in completely spinal cord-transected (Tx) rodents. Using ‘knock-out’ mice (eg, 5-HTR7-/-) and selective antagonists, it has been clearly established that both 5-HTR1A and 5-HTR7 were critically involved in mediating the pro-locomotor effects induced by 8-OH-DPAT (typically referred to as a 5-HTR1A agonist) in Tx animals. Taken together, these in vitro and in vivo data strongly support the idea that 5-HTR1A agonists may eventually become constitutive elements of a novel first-in-class combinatorial treatment aimed at periodically inducing short episodes of treadmill stepping in SCI patients.Keywords: 5-HT agonists, anxiolytics, locomotion, SCI
format article
author Pierre A Guertin
author_facet Pierre A Guertin
author_sort Pierre A Guertin
title Anxiolytics may promote locomotor function recovery in spinal cord injury patients
title_short Anxiolytics may promote locomotor function recovery in spinal cord injury patients
title_full Anxiolytics may promote locomotor function recovery in spinal cord injury patients
title_fullStr Anxiolytics may promote locomotor function recovery in spinal cord injury patients
title_full_unstemmed Anxiolytics may promote locomotor function recovery in spinal cord injury patients
title_sort anxiolytics may promote locomotor function recovery in spinal cord injury patients
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/f41864b083a24af1922bef312e67addf
work_keys_str_mv AT pierreaguertin anxiolyticsmaypromotelocomotorfunctionrecoveryinspinalcordinjurypatients
_version_ 1718401344194215936